Bayside Health
111
0
1
62
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.1%
9 terminated/withdrawn out of 111 trials
87.3%
+0.8% vs industry average
22%
24 trials in Phase 3/4
5%
3 of 62 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (111)
REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study
Role: lead
The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial
Role: lead
Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
Role: lead
Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial
Role: lead
Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
Role: lead
Nitrous Oxide for the Treatment of Major Depressive Disorder
Role: lead
Hyperbaric Oxygen in Lower Leg Trauma
Role: lead
Optimising Cohorts for HIV Cure Interventions
Role: lead
Dexamethasone for Cardiac Surgery-II Trial
Role: lead
Association of Postoperative Anaemia With Patient-centred Outcomes
Role: lead
Nurse-led Antimicrobial Stewardship Intervention to Increase Antibiotic Appropriateness in Residential Aged Care Facilities
Role: lead
An Adaptive Clinical Trial of Antivirals for COVID-19 Infection
Role: lead
Effect of Exercise Training on Salivary Immunoglobulin A in Patients With Chronic Obstructive Pulmonary Disease
Role: lead
Modified Release Posaconazole in Patients With Cystic Fibrosis
Role: lead
fungalAi for Fungal Surveillance & Antifungal Stewardship
Role: lead
rTMS in the Treatment of Bipolar Depression
Role: lead
A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression
Role: lead
TMS in the Treatment of the Sequelae of Closed Brain Injury
Role: lead
Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
Role: lead
Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia
Role: lead